Thomas G. Murray

2.0k total citations
32 papers, 1.5k citations indexed

About

Thomas G. Murray is a scholar working on Nephrology, Pharmacology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Thomas G. Murray has authored 32 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Nephrology, 6 papers in Pharmacology and 6 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Thomas G. Murray's work include Pharmacological Effects and Toxicity Studies (5 papers), Antibiotics Pharmacokinetics and Efficacy (5 papers) and CCD and CMOS Imaging Sensors (3 papers). Thomas G. Murray is often cited by papers focused on Pharmacological Effects and Toxicity Studies (5 papers), Antibiotics Pharmacokinetics and Efficacy (5 papers) and CCD and CMOS Imaging Sensors (3 papers). Thomas G. Murray collaborates with scholars based in United States, United Kingdom and Cyprus. Thomas G. Murray's co-authors include Allan J. Erslev, J. Jaime, Stephen Brown, Brian L. Strom, Gail Morrison, Greg Maislin, Neil H. Shusterman, Suzanne L. West, Orin Miller and Matthew S. Goldberg and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and Annals of Internal Medicine.

In The Last Decade

Thomas G. Murray

32 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas G. Murray United States 15 418 212 205 181 178 32 1.5k
Markku Salmenperä Finland 29 262 0.6× 59 0.3× 102 0.5× 197 1.1× 409 2.3× 109 2.5k
A. E. G. Raine United Kingdom 29 588 1.4× 141 0.7× 447 2.2× 95 0.5× 522 2.9× 83 3.1k
Lynne E. Wagoner United States 21 77 0.2× 150 0.7× 92 0.4× 174 1.0× 313 1.8× 52 3.3k
Robert J. Noveck United States 27 107 0.3× 47 0.2× 99 0.5× 54 0.3× 161 0.9× 70 2.0k
Anthony A. Killeen United States 24 421 1.0× 66 0.3× 189 0.9× 48 0.3× 187 1.1× 86 2.1k
John D. Wallin United States 24 318 0.8× 32 0.2× 258 1.3× 20 0.1× 117 0.7× 67 1.7k
Günter Stein Germany 22 557 1.3× 57 0.3× 115 0.6× 63 0.3× 130 0.7× 67 1.8k
Lerner B. Hinshaw United States 23 229 0.5× 38 0.2× 73 0.4× 89 0.5× 348 2.0× 82 2.1k
W. J. Kox Germany 26 187 0.4× 50 0.2× 92 0.4× 93 0.5× 238 1.3× 71 2.3k
L Chiandussi Italy 25 122 0.3× 118 0.6× 21 0.1× 130 0.7× 285 1.6× 96 2.8k

Countries citing papers authored by Thomas G. Murray

Since Specialization
Citations

This map shows the geographic impact of Thomas G. Murray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas G. Murray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas G. Murray more than expected).

Fields of papers citing papers by Thomas G. Murray

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas G. Murray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas G. Murray. The network helps show where Thomas G. Murray may publish in the future.

Co-authorship network of co-authors of Thomas G. Murray

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas G. Murray. A scholar is included among the top collaborators of Thomas G. Murray based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas G. Murray. Thomas G. Murray is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Andreou, Andreas G., Thomas G. Murray, & Philippe O. Pouliquen. (2013). Signal to symbol converters: Overview, opportunities and challenges. 1–6. 1 indexed citations
2.
Murray, Thomas G., et al.. (2011). Design of a CMOS A2I data converter: Theory, architecture and implementation. 6065. 1–6. 7 indexed citations
3.
Cassidy, Andrew S., Thomas G. Murray, Andreas G. Andreou, & Julius Georgiou. (2011). Evaluating on-chip interconnects for low operating frequency silicon neuron arrays. 2437–2440. 3 indexed citations
4.
Chance, Britton, et al.. (1998). A novel method for fast imaging of brain function, non-invasively, with light. Optics Express. 2(10). 411–411. 208 indexed citations
5.
Thompson, Geoff, et al.. (1987). Enhanced oral bioavailability of meptazinol in cirrhosis.. Gut. 28(3). 248–254. 4 indexed citations
6.
MacGilchrist, A.J., Abigail Cook, G Scobie, et al.. (1986). Pharmacokinetics and pharmacodynamics of intravenous midazolam in patients with severe alcoholic cirrhosis.. Gut. 27(2). 190–195. 136 indexed citations
7.
Scobie, G, Emma J. Agnew, BK Park, et al.. (1984). Effects of cimetidine on carbamazepine auto‐ and hetero‐induction in man.. British Journal of Clinical Pharmacology. 18(3). 411–419. 37 indexed citations
8.
Greenblatt, David J., et al.. (1983). Multiple-Dose Kinetics and Dialyzability of Oxazepam in Renal Insufficiency. ˜The œNephron journals/Nephron journals. 34(4). 234–238. 9 indexed citations
9.
Murray, Thomas G.. (1983). Epidemiologic Study of Regular Analgesic Use and End-Stage Renal Disease. Archives of Internal Medicine. 143(9). 1687–1687. 64 indexed citations
10.
Morrison, G., et al.. (1982). Cefazolin: The cephalosporin (C) antibiotic of choice in chronic ambulatory peritoneal dialysis (CAPD) patients (PTS)?. Kidney International. 21(1). 1 indexed citations
11.
Murray, Thomas G., et al.. (1982). The spectrum of peritonitis (P) in urban chronic ambulatory peritoneal dialysis (CAPD) patients (PTS). Kidney International. 21(1). 1 indexed citations
12.
Murray, Thomas G., et al.. (1981). The Effect of Somatostatin on the Hormonal Abnormalities of End Stage Renal Disease. Journal of International Medical Research. 9(1). 1–5. 1 indexed citations
13.
Murray, Thomas G., et al.. (1980). Ticrynafen in anephric patients: Effects on uric acid and pharmacokinetics. Clinical Pharmacology & Therapeutics. 27(5). 686–689. 6 indexed citations
14.
Barza, Michael, Thomas G. Murray, & Robert J. Hamburger. (1980). Uptake of Gentamicin by Separated, Viable Renal Tubules from Rabbits. The Journal of Infectious Diseases. 141(4). 510–517. 12 indexed citations
15.
Chawla, Rajender K., David H. Lawson, Thomas G. Murray, et al.. (1980). Elevated plasma and urinary guanosine 3':5'-monophosphate and increased production rate in patients with neoplastic diseases.. PubMed. 40(11). 3915–20. 21 indexed citations
16.
Nutter, Donald O., Thomas G. Murray, Steven B. Heymsfield, & Ellen O. Fuller. (1979). The effect of chronic protein-calorie undernutrition in the rat on myocardial function and cardiac function.. Circulation Research. 45(1). 144–152. 65 indexed citations
17.
Jaime, J., Stephen Brown, Orin Miller, Thomas G. Murray, & Allan J. Erslev. (1979). Erythropoietin levels in uremic nephric and anephric patients.. PubMed. 93(3). 449–58. 198 indexed citations
18.
Arger, Peter H., Edward I. Bluth, Thomas G. Murray, & Martin Goldberg. (1976). Analgesic abuse nephropathy. Urology. 7(2). 123–128. 8 indexed citations
19.
Murray, Thomas G. & Matthew S. Goldberg. (1975). Analgesic Abuse and Renal Disease. Annual Review of Medicine. 26(1). 537–550. 64 indexed citations
20.
Oreopoulos, Dimitrios G., Donald R. Taves, H. E. Meema, et al.. (1974). Fluoride and dialysis osteodystrophy: results of a double-blind study.. PubMed. 20A. 203–8. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Markku Salmenperä Breakdown of academic impact, for papers by A. E. G. Raine Breakdown of academic impact, for papers by Lynne E. Wagoner Breakdown of academic impact, for papers by Robert J. Noveck Breakdown of academic impact, for papers by Anthony A. Killeen Breakdown of academic impact, for papers by John D. Wallin Breakdown of academic impact, for papers by Günter Stein Breakdown of academic impact, for papers by Lerner B. Hinshaw Breakdown of academic impact, for papers by W. J. Kox Breakdown of academic impact, for papers by L Chiandussi
Rankless by CCL
2026